Structure of peripheral blood platelets surface in patients with amyotrophic lateral sclerosis and multiple sclerosis

Zhurnal Nevrologii i Psihiatrii imeni S.S. Korsakova

Volumn 105, Issue 3, 2005, Pages 40-42

  Kiktenko, A I ^a   Zlobina, G P ^a   Brusov, O S ^a   Zacharova, M N ^a  

^a NONE

Author keywords

Amyotrophic lateral sclerosis; Multiple sclerosis; Platelets activation; Scanning electronic microscopy

Indexed keywords

AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BLOOD; COMPARATIVE STUDY; HUMAN; MULTIPLE SCLEROSIS; PHYSIOLOGY; SCANNING ELECTRON MICROSCOPY; STATISTICAL ANALYSIS; SURFACE PROPERTY; THROMBOCYTE; THROMBOCYTE AGGREGATION; ULTRASTRUCTURE;

AMYOTROPHIC LATERAL SCLEROSIS; BLOOD PLATELETS; DATA INTERPRETATION, STATISTICAL; HUMANS; MICROSCOPY, ELECTRON, SCANNING; MULTIPLE SCLEROSIS; PLATELET AGGREGATION; SURFACE PROPERTIES;

EID: 17844390661     PISSN: 19977298     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann Neurol 1995; 38: 3: 357-366.
2. Beal M.F. Mitochondria and the pathogenesis of ALS. Brain 2000; 123: 7: 1291-1292.
3. Cluskey S., Ramsden D.B. Mechanisms of neurodegeneration in amyotrophic lateral sclerosis. J Clin Pathol Mol Pathol 2001; 54: 386-392.
4. Curti D., Malaspina A., Facchetti G. et al. Amyotrophic lateral sclerosis: oxidative energy metabolism and calcium homeostasis in peripheral blood lymphocytes. Neurology 1996; 47: 4: 1060-1064.
5. Ferrarese C., Sala G., Riva R. et al. Decreased platelet glutamate uptake in patients with amyotrophic lateral sclerosis. Neurology 2001; 56: 2: 270-272.
6. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983; 33: 11: 1444-1452.
7. Pletscher A. Platelets as models: use and limitations. Experientia 1988; 44: 2: 152-155.
8. Rao J.S., Hantai D., Festoff B.W. Thrombospondin, a platelet alpha-granule and matrix glycoprotein, is increased in muscle basement membrane of patients with amyotrophic lateral sclerosis. J Neurol Sci 1992; 113: 1: 99-107.
9. Singh K.K. Mitochondrial dysfunction is a common phenotype in aging and cancer. Ann N Y Acad Sci 2004; 1019: 260-264.
10. Smirnova I.V., Festoff B. W. Alterations in serum thrombospondin in patients with amyotrophic lateral sclerosis. J Neurol Sci 1994; 127: 2: 207-213.
11. Strong M.J. Progress in clinical neurosciences: the evidence for ALS as a multisystems disorder of limited phenotypic expression. Can J Neurol Sci 2001; 28: 4: 283-298.
12. Swerdlow R.H., Parks J.K., Cassarino D.S. et al. Mitochondria in sporadic amyotrophic lateral sclerosis. Exp Neurol 1998; 153: 1: 135-142.
13. Tangen O., Herman H.J., Marfey P. Gel filtration. A new technique for separation of blood platelets from plasma. Thromb Diath Haemorrh 1971; 25: 2: 268-278.
14. Toescu E.C., Xiong J. Metabolic substrates of neuronal aging. Ann N Y Acad Sci 2004; 1019: 19-23.
15. Vielhaber S., Kunz D., Winkler K. et al. Mitochondrial DNA abnormalities in skeletal muscle of patients with sporadic amyotrophic lateral sclerosis. Brain 2000; 123: 7: 1339-1348.